课题基金 / 基金详情

Studies on the beta cell differentiation signal in AR42J cells and in vivo effect on islet neogenesis in diabetic mice by betacellulin

Studies on the beta cell differentiation signal in AR42J cells and in vivo effect on islet neogenesis in diabetic mice by betacellulin
AR42J细胞β细胞分化信号及βcellulin对糖尿病小鼠胰岛新生作用的体内研究
批准号:
09671056
负责人:
MIYAGAWA Jun-ichiro
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

MIYAGAWA Jun-ichiro的其他基金

相似基金

相关文献

中文摘要
翻译
我们试图阐明β细胞蛋白诱导AR42J细胞分化为胰岛素分泌细胞的机制,以及β细胞蛋白在体内对四氧嘧啶诱导的糖尿病小鼠胰岛新生和糖耐量的影响。在AR42J细胞中,重组人β细胞蛋白刺激诱导胰岛素免疫活性和胞浆中的β颗粒样分泌囊泡。erbB受体酪氨酸的磷酸化主要发生在不能直接与β细胞蛋白结合的erbB2中,提示在AR42J细胞向胰岛素产生的细胞内分化信号中,以异二聚体形式的erbB2的交叉激活是重要的。然而,我们在AR42J细胞表面没有检测到β细胞蛋白特异性受体或结合蛋白。β细胞蛋白主要在胎儿和成人胰腺中表达,我们发现该因子在胰岛的导管细胞和α细胞中产生。在四氧嘧啶诱导的糖尿病小鼠的胰腺中,胰岛新生主要发生在四氧嘧啶灌流的胰岛细胞缺失的部分。胰岛素转录因子IPF1/PDX-1在与新形成的胰岛样细胞团(ICCs)直接相关的导管细胞中检测到。在ICCs中,观察到对包括胰岛素在内的胰腺激素呈双阳性免疫反应的内分泌细胞,提示导管细胞在糖尿病小鼠胰岛新生中起重要作用。在此基础上,我们通过注射重组人β细胞蛋白对糖尿病小鼠体内的作用进行了研究。在用β细胞蛋白治疗的小鼠中,ICCs的数量增加,糖耐量减少。这些结果表明,正如在AR42J细胞中观察到的那样,β细胞蛋白可能是胰腺中的β细胞分化因子。
英文摘要
We tried to clarify the mechanism of differentiation of AR42J cells into insulin-secreting cells induced by betacellulin, and in vivo effects of betacellulin on the islet neogenesis and glucose intolerance in diabetic mice induced by selective perfusion of alloxan.In AR42J cells, stimulation with recombinant human betacellulin induced insulin immunoreactivlty and beta granule-like secretory vesicles in the cytoplasm.Phosphorylation of erbB receptor tyrosine was mainly occurred in erbB2 which could not bind directly to betacellulin, suggesting that crossactivation of erbB2 in the form of heterodimer is important for the intracellular differentiation signaling in AR42J cells into insulin-producing cells.However, it was difficult to clone the cells dominant negative for erbB2 by transfecting mutant form to confirm this result.We could not detect the betacellulin-specific receptor or binding protein on the cell surface of AR42J cells.Betacellulin was expressed predominantly in the fetal and adult pancreas, and we found this factor was produced in duct cells and alpha cells of islets.In the pancreas of diabetic mice induced by selective perfusion of alloxan, islet neogenesis was observed mainly in the alloxan-perfused beta cell-depleted segment.Expression of insulin transscription factor, IPF1/PDX-1 was detected in the duct cells directly associated with newly formed islet-like cell clusters (ICCs).In ICCs, endocrine cells with double positive immunoreactivities to pancreatic hormones including insulin were observed, suggesting duct cells are important for the islet neogenesis in diabetic pancreas.Based on these findings, we examined in vivo effect of betacellulin by injecting recombinant human betacellulin in these diabetic mice.In the mice treated with betacellulin, the number of ICCs was increased, and the glucose intolerance was ameliorated.These results suggested betacellulin, as observed in AR42J cells, may act as beta cell differentiation factor in the pancreas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
H.Kaneto: "Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development" J.Biol.Chem.30(4). 29137-29143 (1997)
H.Kaneto:“胰腺发育过程中肝素结合表皮生长因子样生长因子的表达”J.Biol.Chem.30(4)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
宮川潤一郎: "膵β細胞再生促進療法の可能性" 医学のあゆみ. 187(5). 121-125 (1999)
Junichiro Miyakawa:“促进胰腺β细胞再生的治疗的可能性”医学史187(5)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Waguri.: "Histopathologic study shows a characteristic lymphocyticinfiltration in Japanesepatients with IDDM" Endocrine J.44(1). 23-33 (1997)
M.Waguri.:“组织病理学研究显示日本 IDDM 患者存在特征性淋巴细胞浸润”Endocrine J.44(1)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Iwahashi.: "Molecular mechanism of pancreatic beta-cell destruction in autoimmune diabetes : potential targets for preventive therapy" Cytokines Cell.Mol.Ther.4. 45-51 (1998)
H.Iwahashi.:“自身免疫性糖尿病中胰腺β细胞破坏的分子机制:预防性治疗的潜在目标”细胞因子Cell.Mol.Ther.4。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 43 条
    Mechanism of differentiation and growth of pancreatic βcells by newly identified growth factor, NTAK, and its application for regenerative medicine in diabetes mellitus
    • 批准号:
      18591006
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2006
    • 负责人:
      MIYAGAWA Jun-ichiro
    • 依托单位:
    Development of regeneration therapy for type 1 diabetes by induction of β cell neogenesis
    • 批准号:
      13671154
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      MIYAGAWA Jun-ichiro
    • 依托单位:
    Establishment of the method for gene therapy of β cell regeneration by non-invasive gene delivery via pancreatic duct
    • 批准号:
      12557089
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.59万
    • 财政年份:
      2000
    • 负责人:
      MIYAGAWA Jun-ichiro
    • 依托单位:
    Analysis of β cell differentiation in diabetic pancreas induced by betacellulin with special reference to the role of Pax family gene
    • 批准号:
      11671087
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      MIYAGAWA Jun-ichiro
    • 依托单位:
    国内基金
    海外基金
    Betacellulin对胰岛保护作用的信号转导机制研究
    • 批准号:
      30700387
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      17.0万元
    • 批准年份:
      2007
    • 负责人:
      李虹
    • 依托单位: